Advertisement

Complete Mesocolic Excision and Extent of Lymphadenectomy for the Treatment of Colon Cancer

  • Tsuyoshi Konishi
    Correspondence
    Corresponding author. Department of Colon and Rectal Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1484, PO Box 301402, Houston, TX 77230.
    Affiliations
    Department of Colon and Rectal Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1484, PO Box 301402, Houston, TX 77230, USA
    Search for articles by this author
  • Y. Nancy You
    Affiliations
    Department of Colon and Rectal Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1484, PO Box 301402, Houston, TX 77230, USA
    Search for articles by this author
Published:March 05, 2022DOI:https://doi.org/10.1016/j.soc.2021.11.009

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bass E.M.
        • Del Pino A.
        • Tan A.
        • et al.
        Does preoperative stoma marking and education by the enterostomal therapist affect outcome?.
        Dis Colon Rectum. 1997; 40: 440-442
        • West N.P.
        • Hohenberger W.
        • Weber K.
        • et al.
        Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon.
        J Clin Oncol. 2010; 28: 272-278
        • Bertelsen C.A.
        • Neuenschwander A.U.
        • Jansen J.E.
        • et al.
        Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study.
        Lancet Oncol. 2015; 16: 161-168
        • Cho M.S.
        • Baek S.J.
        • Hur H.
        • et al.
        Modified complete mesocolic excision with central vascular ligation for the treatment of right-sided colon cancer: long-term outcomes and prognostic factors.
        Ann Surg. 2015; 261: 708-715
        • Hohenberger W.
        • Weber K.
        • Matzel K.
        • et al.
        Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome.
        Colorectal Dis. 2009; 11 ([discussion 355–64]): 354-364
        • Konishi T.
        • Shimada Y.
        • Hsu M.
        • et al.
        Contemporary validation of a nomogram predicting colon cancer recurrence, revealing all-stage improved outcomes.
        JNCI Cancer Spectr. 2019; 3: pkz015
        • West N.P.
        • Kobayashi H.
        • Takahashi K.
        • et al.
        Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation.
        J Clin Oncol. 2012; 30: 1763-1769
        • Hashiguchi Y.
        • Muro K.
        • Saito Y.
        • et al.
        Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.
        Int J Clin Oncol. 2020; 25: 1-42
        • Kitano S.
        • Inomata M.
        • Mizusawa J.
        • et al.
        Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial.
        Lancet Gastroenterol Hepatol. 2017; 2: 261-268
        • Kennedy R.H.
        • Francis E.A.
        • Wharton R.
        • et al.
        Multicenter randomized controlled trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme: EnROL.
        J Clin Oncol. 2014; 32: 1804-1811
        • Nelson G.
        • Kiyang L.N.
        • Crumley E.T.
        • et al.
        Implementation of enhanced recovery after surgery (ERAS) across a provincial healthcare system: the ERAS Alberta colorectal surgery experience.
        World J Surg. 2016; 40: 1092-1103
        • Varadhan K.K.
        • Lobo D.N.
        • Ljungqvist O.
        Enhanced recovery after surgery: the future of improving surgical care.
        Crit Care Clin. 2010; 26 (x): 527-547
        • Argiles G.
        • Tabernero J.
        • Labianca R.
        • et al.
        Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.
        Ann Oncol. 2020; 31: 1291-1305
        • Benson A.B.
        • Venook A.P.
        • Al-Hawary M.M.
        • et al.
        Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology.
        J Natl Compr Canc Netw. 2021; 19: 329-359
        • Hameed I.
        • Aggarwal P.
        • Weiser M.R.
        Robotic extended right hemicolectomy with complete mesocolic excision and D3 lymph node dissection.
        Ann Surg Oncol. 2019; 26: 3990-3991
        • Yang Y.
        • Peacock O.
        • Malakorn S.
        • et al.
        Superior mesenteric vein-first approach for robotic salvage surgery with indocyanine green fluorescence angiography.
        Ann Surg Oncol. 2020; 27: 3500
        • Heald R.J.
        • Ryall R.D.
        Recurrence and survival after total mesorectal excision for rectal cancer.
        Lancet. 1986; 1: 1479-1482
        • Morikawa E.
        • Yasutomi M.
        • Shindou K.
        • et al.
        Distribution of metastatic lymph nodes in colorectal cancer by the modified clearing method.
        Dis Colon Rectum. 1994; 37: 219-223
        • Toyota S.
        • Ohta H.
        • Anazawa S.
        Rationale for extent of lymph node dissection for right colon cancer.
        Dis Colon Rectum. 1995; 38: 705-711
        • Merkel S.
        • Weber K.
        • Matzel K.E.
        • et al.
        Prognosis of patients with colonic carcinoma before, during and after implementation of complete mesocolic excision.
        Br J Surg Aug. 2016; 103: 1220-1229
        • Bertelsen C.A.
        • Neuenschwander A.U.
        • Jansen J.E.
        • et al.
        5-year outcome after complete mesocolic excision for right-sided colon cancer: a population-based cohort study.
        Lancet Oncol. 2019; 20: 1556-1565
        • Bernhoff R.
        • Martling A.
        • Sjovall A.
        • et al.
        Improved survival after an educational project on colon cancer management in the county of Stockholm--a population based cohort study.
        Eur J Surg Oncol. 2015; 41: 1479-1484
        • Gao Z.
        • Wang C.
        • Cui Y.
        • et al.
        Efficacy and safety of complete mesocolic excision in patients with colon cancer: three-year results from a prospective, nonrandomized, double-blind, controlled trial.
        Ann Surg. 2020; 271: 519-526
        • Crane J.
        • Hamed M.
        • Borucki J.P.
        • et al.
        Complete mesocolic excision versus conventional surgery for colon cancer: a systematic review and meta-analysis.
        Colorectal Dis. 2021; 23: 1670-1686
        • Emmanuel A.
        • Haji A.
        Complete mesocolic excision and extended (D3) lymphadenectomy for colonic cancer: is it worth that extra effort? A review of the literature.
        Int J Colorectal Dis. 2016; 31: 797-804
        • Mazzarella G.
        • Muttillo E.M.
        • Picardi B.
        • et al.
        Complete mesocolic excision and D3 lymphadenectomy with central vascular ligation in right-sided colon cancer: a systematic review of postoperative outcomes, tumor recurrence and overall survival.
        Surg Endosc. 2021; 35: 4945-4955
        • West N.P.
        • Morris E.J.
        • Rotimi O.
        • et al.
        Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study.
        Lancet Oncol. 2008; 9: 857-865
      1. Japanese classification of colorectal, appendiceal, and anal carcinoma: the 3d english edition [Secondary Publication].
        J Anus Rectum Colon. 2019; 3: 175-195
        • Kobayashi H.
        • West N.P.
        • Takahashi K.
        • et al.
        Quality of surgery for stage III colon cancer: comparison between England, Germany, and Japan.
        Ann Surg Oncol. 2014; 21: S398-S404
        • Kanemitsu Y.
        • Komori K.
        • Kimura K.
        • et al.
        D3 lymph node dissection in right hemicolectomy with a no-touch isolation technique in patients with colon cancer.
        Dis Colon Rectum. 2013; 56: 815-824
        • Nagasaki T.
        • Akiyoshi T.
        • Fujimoto Y.
        • et al.
        Prognostic impact of distribution of lymph node metastases in stage III colon cancer.
        World J Surg. 2015; 39: 3008-3015
        • Yamaoka Y.
        • Kinugasa Y.
        • Shiomi A.
        • et al.
        The distribution of lymph node metastases and their size in colon cancer.
        Langenbecks Arch Surg. 2017; 402: 1213-1221
        • Kotake K.
        • Mizuguchi T.
        • Moritani K.
        • et al.
        Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer.
        Int J Colorectal Dis. 2014; 29: 847-852
        • Karachun A.
        • Panaiotti L.
        • Chernikovskiy I.
        • et al.
        Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial).
        Br J Surg. 2020; 107: 499-508
        • Xu L.
        • Su X.
        • He Z.
        • et al.
        Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.
        Lancet Oncol. 2021; 22: 391-401
        • Shiozawa M.
        • Ueno H.
        • Shiomi A.
        • et al.
        Study protocol for an international prospective observational cohort study for optimal bowel resection extent and central radicality for colon cancer (T-REX study).
        Jpn J Clin Oncol. 2021; 51: 145-155
        • Jayne D.G.
        • Thorpe H.C.
        • Copeland J.
        • et al.
        Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer.
        Br J Surg. 2010; 97: 1638-1645
        • Buunen M.
        • Veldkamp R.
        • Hop W.C.
        • et al.
        Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial.
        Lancet Oncol. 2009; 10: 44-52
        • Fleshman J.
        • Sargent D.J.
        • Green E.
        • et al.
        Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial.
        Ann Surg. 2007; 246 ([discussion 654–62]): 655-662
        • Lacy A.M.
        • Delgado S.
        • Castells A.
        • et al.
        The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer.
        Ann Surg. 2008; 248: 1-7
        • Schiphorst A.H.
        • Verweij N.M.
        • Pronk A.
        • et al.
        Non-surgical complications after laparoscopic and open surgery for colorectal cancer - A systematic review of randomised controlled trials.
        Eur J Surg Oncol. 2015; 41: 1118-1127
        • Sammour T.
        • Malakorn S.
        • Thampy R.
        • et al.
        Selective central vascular ligation (D3 lymphadenectomy) in patients undergoing minimally invasive complete mesocolic excision for colon cancer: optimizing the risk-benefit equation.
        Colorectal Dis. 2020; 22: 53-61
        • Yamamoto S.
        • Inomata M.
        • Katayama H.
        • et al.
        Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan Clinical Oncology Group Study JCOG 0404.
        Ann Surg. 2014; 260: 23-30
        • Nakajima K.
        • Inomata M.
        • Akagi T.
        • et al.
        Quality control by photo documentation for evaluation of laparoscopic and open colectomy with D3 resection for stage II/III colorectal cancer: Japan Clinical Oncology Group Study JCOG 0404.
        Jpn J Clin Oncol. 2014; 44: 799-806
        • Chang Y.S.
        • Wang J.X.
        • Chang D.W.
        A meta-analysis of robotic versus laparoscopic colectomy.
        J Surg Res. 2015; 195: 465-474
        • Lim S.
        • Kim J.H.
        • Baek S.J.
        • et al.
        Comparison of perioperative and short-term outcomes between robotic and conventional laparoscopic surgery for colonic cancer: a systematic review and meta-analysis.
        Ann Surg Treat Res. 2016; 90: 328-339
        • Zarak A.
        • Castillo A.
        • Kichler K.
        • et al.
        Robotic versus laparoscopic surgery for colonic disease: a meta-analysis of postoperative variables.
        Surg Endosc. 2015; 29: 1341-1347
        • Athanasiou C.D.
        • Markides G.A.
        • Kotb A.
        • et al.
        Open compared with laparoscopic complete mesocolic excision with central lymphadenectomy for colon cancer: a systematic review and meta-analysis.
        Colorectal Dis. 2016; 18: O224-O235
        • Khan M.A.
        • Hakeem A.R.
        • Scott N.
        • et al.
        Significance of R1 resection margin in colon cancer resections in the modern era.
        Colorectal Dis. 2015; 17: 943-953
        • Healy M.A.
        • Peacock O.
        • Hu C.Y.
        • et al.
        High rate of positive circumferential resection margin in colon cancer: a national appraisal and call for action.
        Ann Surg. 2020; 262: 891-898
        • Goffredo P.
        • Zhou P.
        • Ginader T.
        • et al.
        Positive circumferential resection margins following locally advanced colon cancer surgery: risk factors and survival impact.
        J Surg Oncol. 2020; 121: 538-546
        • Prevost G.A.
        • Odermatt M.
        • Furrer M.
        • et al.
        Postoperative morbidity of complete mesocolic excision and central vascular ligation in right colectomy: a retrospective comparative cohort study.
        World J Surg Oncol. 2018; 16: 214
        • Bertelsen C.A.
        • Neuenschwander A.U.
        • Jansen J.E.
        • et al.
        Short-term outcomes after complete mesocolic excision compared with 'conventional' colonic cancer surgery.
        Br J Surg. 2016; 103: 581-589
        • Wang C.
        • Gao Z.
        • Shen K.
        • et al.
        Safety, quality and effect of complete mesocolic excision vs non-complete mesocolic excision in patients with colon cancer: a systemic review and meta-analysis.
        Colorectal Dis. 2017; 19: 962-972